CA3187665A1 - Therapy of post-operative nausea and vomiting - Google Patents

Therapy of post-operative nausea and vomiting

Info

Publication number
CA3187665A1
CA3187665A1 CA3187665A CA3187665A CA3187665A1 CA 3187665 A1 CA3187665 A1 CA 3187665A1 CA 3187665 A CA3187665 A CA 3187665A CA 3187665 A CA3187665 A CA 3187665A CA 3187665 A1 CA3187665 A1 CA 3187665A1
Authority
CA
Canada
Prior art keywords
amisulpride
patient
use according
patients
bmi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3187665A
Other languages
English (en)
French (fr)
Inventor
Julian Clive Gilbert
Gabriel Fox
Robert William Gristwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acacia Pharma Ltd
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2010361.0A external-priority patent/GB202010361D0/en
Priority claimed from GBGB2108238.3A external-priority patent/GB202108238D0/en
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Publication of CA3187665A1 publication Critical patent/CA3187665A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3187665A 2020-07-06 2021-07-06 Therapy of post-operative nausea and vomiting Pending CA3187665A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2010361.0 2020-07-06
GBGB2010361.0A GB202010361D0 (en) 2020-07-06 2020-07-06 Therapy of post-operative nausea and vomiting
GBGB2108238.3A GB202108238D0 (en) 2021-06-09 2021-06-09 Thearpy of post-operative nausea and vomiting
GB2108238.3 2021-06-09
PCT/GB2021/051720 WO2022008901A1 (en) 2020-07-06 2021-07-06 Therapy of post-operative nausea and vomiting

Publications (1)

Publication Number Publication Date
CA3187665A1 true CA3187665A1 (en) 2022-01-13

Family

ID=77021661

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3187665A Pending CA3187665A1 (en) 2020-07-06 2021-07-06 Therapy of post-operative nausea and vomiting

Country Status (11)

Country Link
US (1) US20230263770A1 (https=)
EP (1) EP4175631A1 (https=)
JP (1) JP2023538216A (https=)
KR (1) KR20230035095A (https=)
CN (1) CN115867271A (https=)
AU (1) AU2021305446A1 (https=)
BR (1) BR112023000167A2 (https=)
CA (1) CA3187665A1 (https=)
IL (1) IL299649A (https=)
MX (1) MX2023000283A (https=)
WO (1) WO2022008901A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250152595A1 (en) * 2023-11-09 2025-05-15 Lisa Myslinski Medication to alleviate nausea with or without vomiting, vertigo, and pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
GB201702250D0 (en) * 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Also Published As

Publication number Publication date
CN115867271A (zh) 2023-03-28
US20230263770A1 (en) 2023-08-24
JP2023538216A (ja) 2023-09-07
EP4175631A1 (en) 2023-05-10
AU2021305446A1 (en) 2023-02-02
MX2023000283A (es) 2023-02-09
BR112023000167A2 (pt) 2023-01-31
KR20230035095A (ko) 2023-03-10
WO2022008901A1 (en) 2022-01-13
IL299649A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
AU2024203155B2 (en) Rescue treatment of post operative nausea and vomiting
US20240050403A1 (en) Therapy of post-operative emesis with amisulpride
US20230263770A1 (en) Therapy of post-operative nausea and vomiting
EA048577B1 (ru) Терапия послеоперационной тошноты и рвоты
NZ792875A (en) Therapy of post-operative emesis with amisulpride
HK40091212A (zh) 术後恶心和呕吐的疗法
CA3052535C (en) Rescue treatment of post operative nausea and vomiting
EA044539B1 (ru) Терапия постоперационной рвоты амисульпридом
HK40005558A (en) Therapy of post-operative emesis with amisulpride
JPWO2018146490A5 (https=)
EA042759B1 (ru) Экстренное лечение постоперационной тошноты и рвоты

Legal Events

Date Code Title Description
D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20250109

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20250109

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250109

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250114

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250114

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250114

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250114

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250430

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250505

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250627

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250627

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20251215

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-T10-T11-T100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXTENSION OF TIME FOR TAKING ACTION REQUEST RECEIVED

Effective date: 20260415